Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Crinetics Pharmaceuticals Inc buy BiotechBee

Start price
€16.20
03.09.23 / 60%
Target price
€20.00
30.11.25
Performance (%)
75.31%
End price
€28.40
01.10.23
Summary
This prediction ended on 01.10.23 with a price of €28.40. With a performance of 75.31% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Crinetics Pharmaceuticals Inc where he still thinks Crinetics Pharmaceuticals Inc is a Buy. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m
Crinetics Pharmaceuticals Inc 1.754% 1.754%
iShares Core DAX® -0.268% 5.471%
iShares Nasdaq 100 1.854% 7.851%
iShares Nikkei 225® 0.284% 1.729%
iShares S&P 500 1.178% 5.269%

According to BiotechBee what are the pros and cons of Crinetics Pharmaceuticals Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 75.31%
Target price 20.000
Change
Ends at 30.11.25

Buy mit Kursziel 20,0

In the thread Trading Crinetics Pharmaceuticals Inc
Prediction Buy
Perf. (%) 75.31%
Target price 20.000
Change
Ends at 30.11.25

Buy beendet

Current prediction by BiotechBee for Crinetics Pharmaceuticals Inc

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€30.80
10.12.23
€45.00
30.06.25
52.60%
15.05.24

Could be very worthwhile Investment >20% year